Validation of a two-stage automated screening pipeline for medical systematic reviews: a stratified concordance study with three independent human reviewers, using PABAK and Gwet's AC1
Pirani, E.; Costazza, D.; Berti, P. P.
Show abstract
Background. Large language models (LLMs) are increasingly used to automate title-abstract screening in systematic reviews, but validation studies typically report sensitivity, specificity, or Cohen's kappa: metrics that are unstable under the low and unbalanced prevalence that characterises most reviews. No previous study has simultaneously combined a medical topic; a hybrid two-stage pipeline (rules + LLM); a three-way classification with a separately sampled uncertain class; stratified sampling with three independent human reviewers; and dual reporting of prevalence-robust coefficients (PABAK and Gwet's AC1). Objective. To validate a two-stage automated screening pipeline (a rule-based Python script followed by a reproducible LLM adjudication of uncertain records) against three independent human reviewers in a medical systematic review on high on-treatment platelet reactivity (HTPR), aspirin resistance, and carotid plaque. The primary validation target is the Stage 1 automatic-exclusion decision (670/904 records), which is the workload the pipeline is designed to take off the human reviewer. Methods. From 904 screened records (Stage 1: 131 INCLUDE, 670 EXCLUDE, 94 UNCERTAIN; Stage 2 LLM via API, temperature = 0: 11 INCLUDE, 83 EXCLUDE), a stratified sample of 185 records (50 per Stage 1 stratum + 35 Stage 2; seed = 42) was judged independently and blind to the automated labels by three physicians: E.P. (pipeline designer), D.C. and P.P.B. (both external to the thesis project). Concordance was quantified with sensitivity, specificity, PABAK (q = 3 throughout), Gwet's AC1, work saved over sampling (WSS), and number needed to read (NNR), AI versus each reviewer and between reviewers, overall and by stratum. Majority labels (2 of 3) are reported as a supplementary panel; they do not replace pairwise tables as the primary reference for sensitivity. Results. On the primary target, Stage1-EXCLUDE concordance was PABAK = AC1 = 1.000 versus E.P. (48/48) and versus D.C. (50/50), and PABAK = 0.940 / AC1 = 0.959 versus Berti (48/50 EXCLUDE, 2 UNCERTAIN). That stratum is 670/904 records (74.1%). Pairwise human agreement was highest between the two external readers (Costazza vs Berti: PABAK = 0.854, AC1 = 0.881) and lower when E.P. was one of the pair (0.703 / 0.774 vs Costazza; 0.621 / 0.702 vs Berti). AI versus each human remained poor (PABAK 0.225 / 0.205 / 0.222). Majority labels on 185 records were 146 EXCLUDE / 27 UNCERTAIN / 4 INCLUDE / 8 NO_MAJORITY. The machine labelled INCLUDE 0 of the 4 majority-INCLUDE records (74, 75, 76, 80). Overall sensitivity was 0.800 versus E.P. (8/10; false negatives 623, 712), 0.500 versus D.C. (1/2; false negative 76), and 0.833 versus Berti (5/6; false negative 76). Versus majority the false-negative count is 1 (record 76); records 623 and 712 are majority EXCLUDE. Stage1-INCLUDE sensitivity of 1.000 is tautological. WSS = 74.1% describes the exclusion stratum only. Conclusions. What this study validates, now with three independent physicians, is automatic exclusion at Stage 1. Fine classification of INCLUDE records is not validated: humans do not agree on which residual records are INCLUDE (triple INCLUDE intersection = record 74 only), Stage 2 missed most of the few human INCLUDE labels it received, and the machine recovered none of the four majority-INCLUDE records. Domain-familiarity as an explanation of INCLUDE divergence remains a hypothesis, not a measured variable.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Use of unstructured text in prognostic clinical prediction models: a systematic review 94%
- A Web-based Tool for Automatically linking Clinical Trials to their Publications 93%
- Beyond Metrics to Methods: A Scoping Review of Large Language Models for Detection of Social Drivers of Health in Clinical Notes 93%
Similar papers in this journal
- Evaluation of SURUS: a Named Entity Recognition System to Extract Knowledge from Interventional Study Records 95%
- Completeness of reporting of clinical prediction models developed using supervised machine learning: A systematic review 94%
- Approaches in Analyzing Predictors of Trial Failure: A Scoping Review and Meta-epidemiological study 93%
Similar papers in this journal
- GPT for RCTs?: Using AI to measure adherence to reporting guidelines 94%
- Agreeability testing of AMSTAR-PF, a tool for quality appraisal of systematic reviews of prognostic factor studies 93%
- Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions 92%
Similar papers in this journal
- Exploring scalable assessment methods for terminated trials in ClinicalTrials.gov: A cohort analysis of German and Californian trials 93%
- Clinical code sets and the problem of redundancy in code set repositories 93%
- Introducing the EMPIRE Index: A novel, value-based metric framework to measure the impact of medical publications 93%
Similar papers in this journal
- Large language models for conducting systematic reviews: on the rise, but not yet ready for use – a scoping review 93%
- The use of the Registered Reports format for publication of randomized clinical trials: a cross-sectional study 92%
- Large-scale validation of the Prediction model Risk Of Bias ASsessment Tool (PROBAST) using a short form: high risk of bias models show poorer discrimination 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.